Publications by authors named "D McCurdy"

The objective of this study was to determine the effect of limiting forage provision in pre-weaned calves on ruminal pH and short chain fatty acid (SCFA) transport capacity during the pre-weaning period. Twelve Jersey bull calves (age = 1.9 ± 0.

View Article and Find Full Text PDF

Systemic autoinflammatory diseases (SAID) are a growing family of disorders of the innate immune system. Over the years, there have been changes in the definition, classification and nomenclature of SAID as new syndromes and pathophysiologic mechanisms continue to be described. Recognizing the clinical manifestations of SAID is important for their early diagnosis and management.

View Article and Find Full Text PDF

Pediatric antiphospholipid syndrome (APS) is characterized by autoantibodies directed against protein complexes on cellular membranes and leads to a prothrombotic, proinflammatory state. A child with APS may present with venous, arterial, or small vessel thrombosis. Other manifestations of APS include nonthrombotic manifestations, such as hematologic and neurologic symptoms.

View Article and Find Full Text PDF

Objectives: Families that contain multiple siblings affected with childhood onset of systemic lupus erythematosus (SLE) likely have strong genetic predispositions. We performed whole exome sequencing (WES) to identify familial rare risk variants and to assess their effects in lupus.

Methods: Sanger sequencing validated the two ultra-rare, predicted pathogenic risk variants discovered by WES and identified additional variants in 562 additional patients with SLE.

View Article and Find Full Text PDF
Article Synopsis
  • Mesenchymal stem cells (MSCs) are now considered medicinal signaling cells due to their role in maintaining tissue health through immune regulation and promoting blood vessel formation.
  • Over the past 20 years, numerous studies have explored MSC applications in treating various illnesses in adults and, to a lesser extent, neonates, particularly for autoimmune diseases like multiple sclerosis and Crohn's disease.
  • This review discusses the current advancements in MSC therapy, including their preparation and safety, mechanisms of action, and documented outcomes, with a focus on advancing multicenter clinical trials for treating severe autoimmune diseases in children.
View Article and Find Full Text PDF